CAS 126550-86-5
:ALPHA-D-GAL-[1->4]-BÊTA-D-GAL-[1->4]-BÊTA-D-GLC-1->O-SPHINGOSINE
- Globotriaosylsphingosine
- Α-D-Gal-(1→4)-Β-D-Gal-(1→4)-Β-D-Glc-1→O-Sphingosine
- Globotriaosyl Lysosphingolipid
- Globotriaosylsphingosine from porcine blood
- (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
(2R,3R,4S,5R,6R)-2-(((2R,3R,4R,5R,6S)-6-(((2R,3S,4R,5R,6R)-6-(((2S,3R,E)-2-Amino-3-hydroxyoctadec-4-en-1-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-4,5-dihydroxy-2-(hydroxyme
CAS :(2R,3R,4S,5R,6R)-2-(((2R,3R,4R,5R,6S)-6-(((2R,3S,4R,5R,6R)-6-(((2S,3R,E)-2-Amino-3-hydroxyoctadec-4-en-1-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-4,5-dihydroxy-2-(hydroxymeDegré de pureté :97%Masse moléculaire :785.92g/molLyso-Globotriaosylceramide (d18:1)
CAS :Lyso-Gb3, lacking fatty acyl, binds Stx1 with cholesterol and phosphatidylcholine, not Stx2; lowers neutrophil viability; accumulates in Fabry disease.Formule :C36H67NO17Couleur et forme :SolidMasse moléculaire :785.922lyso-Ceramide Trihexoside
CAS :Formule :C36H67NO17Degré de pureté :>99%Couleur et forme :SolidMasse moléculaire :785.92Globotriaosylceramide Sphingosine
CAS :Produit contrôléApplications Globotriaosylceramide Sphingosine tert-Butyldimethylsilyl is a Fabry disease biomarker.
References Dupont, F.O., et. al.: Curr. Med. Chem., 20, 280 (2013); Liao, H., et. al.: Clinica Chimica Acta, 426, 114 (2013)Formule :C36H67NO17Couleur et forme :NeatMasse moléculaire :785.914Globotriaosylsphingosine
CAS :Globotriaosylsphingosine is dramatically increased in plasma of classically affected male Fabry patients and plasma and tissues of Fabry mice. Globotriaosylsphingosine was shown to be an inhibitor of α-galactosidase A activity. Furthermore, exposure of smooth muscle cells, but not fibroblasts, to globotriaosylsphingosine at concentrations observed in plasma of patients promotes proliferation. It was suggested that measurement of circulating globotriaosylsphingosine would be useful to monitor Fabry disease and may contribute to a better understanding of the disorder.
Formule :C36H67NO17Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :785.91 g/mol





